Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation (Tables)

v3.10.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Nov. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Valuation assumptions The fair value of the stock option grants in fiscal years 2018 and 2017 were estimated on the date of the grant using a Black-Scholes valuation model and the assumptions in the following table:

Assumptions:
Option Grant Date
Risk-free Interest Rate
Dividend Yield
Stock Volatility
Option Term (years)
June 20, 2017
1.77
%
%
36.37
%
10
October 2, 2017
1.31
%
%
36.73
%
5
June 20, 2018
2.80
%
%
37.14
%
10
June 20, 2018
2.36
%
%
37.14
%
5
Activity of share-based payment award A summary of stock option activity for the Company is as follows:
 
Number of Options
Weighted-Average Exercise Price
Weighted-Average Remaining Term (years)
Aggregate Intrinsic Value
Outstanding at November 30, 2016
564,000
$3.25
5.83
 
Granted
307,500
3.30
 
 
Exercised
 
 
Canceled or Forfeited
 
 
Outstanding at November 30, 2017
871,500
$3.27
6.00
 
Granted
420,000
 
 
 
Exercised
 
 
 
Canceled or Forfeited
177,500
 
 
 
Outstanding at November 30, 2018
1,114,000
$3.11
7.50
Future amortization expense A summary of the future amortization expense of stock options outstanding as of November 30, 2018 is as follows:
For the years ended November 30,
2019
2020
2021
2022
2023
$292,994
$190,217
$169,124
$119,973
$46,453

Schedule of shares authorized by exercise price range The following table summarizes information about currently outstanding and vested stock options at November 30, 2018:
 
 
Weighted-Average Remaining Term (years)
 
 
Number of Options Granted
Number of Option Shares Vested
Exercise Price
$2.85
270,000

9.56

$2.85
150,000

4.55

$3.03
14,000

2.85
5,600

$3.16
225,000

2.00
225,000

$3.18
10,000

6.36
6,000

$3.30
205,000

8.56
41,000

$3.30
75,000

3.84
75,000

$3.35
130,000

7.56
52,000

$3.48
35,000

6.10
21,000

Total
1,114,000

 
425,600